Expired diagnosis? - The potential of exhaled breath analysis;Gehauchte diagnosen? Zum potenzial von atemkondensatuntersuchungen

Pneumologie

Volumn 58, Issue 4, 2004, Pages 230-237

  Gessner, C ^a   Hammerschmidt, S ^a   Kuhn, H ^a   Wirtz, H ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; NITRITE; PROTEIN P53;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; ASTHMA; BREATH ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; EXPIRED AIR; GENE MUTATION; HUMAN; INFLAMMATION; LUNG NON SMALL CELL CANCER; LUNG TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TIDAL VOLUME; VALIDATION PROCESS;

BREATH TESTS; CYSTIC FIBROSIS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 2642527789     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818411     Document Type: Review

References (99)

1. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163 (7): 1693-1722
2. Ricciardolo FL. Multiple roles of nitric oxide in the airways. Thorax 2003; 58 (2): 175-182
3. Paredi P, Kharitonov SA, Barnes PJ. Analysis of expired air for oxidation products. Am J Respir Crit Care Med 2002; 166 (12 Pt 2): S31-37
4. Silkoff PE, Martin D, Pak J et al. Exhaled nitric oxide correlated with induced sputum findings in COPD. Chest 2001; 119 (4): 1049-1055
5. Blease K, Kunkel SL, Hogaboam CM. Acute inhibition of nitric oxide exacerbates airway hyperresponsiveness, eosinophilia and C-C chemokine generation in a murine model of fungal asthma. Inflamm Res 2000; 49 (6): 297-304
6. Feder LS, Stelts D, Chapman RW et al. Role of nitric oxide on eosinophilic lung inflammation in allergic mice. Am J Respir Cell Mol Biol 1997; 17 (4): 436-442
7. Strunk RC, Szefler SJ, Phillips BR et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol 2003; 112 (5): 883-892
8. Nogami H, Shoji S, Nishima S. Exhaled nitric oxide as a simple assessment of airway hyperresponsiveness in bronchial asthma and chronic cough patients. J Asthma 2003; 40 (6): 653-659
9. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999; 160 (6): 2104-2117
10. Fairchild CI, Stampfer JF. Particle concentration in exhaled breath. Am Ind Hyg Assoc J 1987; 48 (11): 948-949
11. Jorres RA, Holz O. [Non-invasive inflammation monitoring]. Pneumologie 2001; 55 (9): 406-408
12. Becher G, Beck E, Rothe M et al. Sammlung von nichtgasförmigen Bestandteilen des Ausatemluft durch Ausfrieren. Medizintechnik 1997; 117: 89-95
13. Griese M, Noss J, Bredow C von. Protein pattern of exhaled breath condensate and saliva. Proteomics 2002; 2 (6): 690-696
14. Effros RM, Hoagland KW, Bosbous M et al. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 2002; 165 (5): 663-669
15. Gessner C, Kuhn H, Seyfarth HJ et al. Factors influencing breath condensate volume. Pneumologie 2001; 55 (9): 414-419
16. Vass G, Huszar E, Barat E et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. Am J Respir Crit Care Med 2003; 167 (6): 850-855
17. Huszar E, Vass G, Vizi E et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 2002; 20 (6): 1393-1398
18. Begin R, Drapeau G, Boileau R et al. Enzyme activities of lung lavage in asbestosis. Clin Biochem 1986; 19 (4): 240-243
19. Rao S. Amylase in bronchial washings as an aid to early diagnosis of bronchogenic carcinoma. J Assoc Physicians India 1995; 43 (6): 400
20. Kietzmann D, Kahl R, Muller M et al. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 1993; 19 (2): 78-81
21. Corradi M, Rubinstein I, Andreoli R et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167 (10): 1380-1386
22. Corradi M, Folesani G, Andreoli R et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003; 167 (3): 395-399
23. Montuschi P, Ragazzoni E, Valente S et al. Ciabattoni. Validation of leukotriene B4 measurements in exhaled breath condensate. Inflamm Res 2003; 52 (2): 69-73
24. Gessner C, Hammerschmidt S, Kuhn H et al. Exhaled breath condensate acidification in acute lung injury. Respir Med 2003; 97 (11): 1188-1194
25. Montuschi P, Ragazzoni E, Valente S et al. Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. Inflamm Res 2003; 52 (12): 502-507
26. Bucchioni E, Kharitonov SA, Allegra L et al. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 2003; 97 (12): 1299-1302
27. Carpagnano GE, Resta O, Foschino-Barbaro MP et al. Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. Int J Biol Markers 2002; 17 (2): 141-145
28. Carpagnano GE, Barnes PJ, Geddes DM et al. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 2003; 167 (8): 1109-1112
29. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP et al. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003; 21 (4): 589-593
30. Shahid SK, Kharitonov SA, Wilson NM et al. Increased interleukin-4 and decreased interferon-γ in exhaled breath condensate of children with asthma. Am J Respir Crit Care Med 2002; 165 (9): 1290-1293
31. Scheideler L, Manke HG, Schwulera U et al. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? Am Rev Respir Dis 1993; 148 (3): 778-784
32. Effros RM, Biller J, Foss B et al. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 2003; 168 (12): 1500-1505
33. Gessner C, Hammerschmidt S, Kuhn H et al. Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury. Chest 2003; 124 (3): 1046-1052
34. Conner GE, Salathe M, Forteza R. Lactoperoxidase and hydrogen peroxide metabolism in the airway. Am J Respir Crit Care Med 2002; 166 (12 Pt 2): S57-61
35. Horvath I, MacNee W, Kelly FJ et al. "Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. Eur Respir J 2001; 18 (2): 420-430
36. Schleiss MB, Holz O, Behnke M et al. The concentration of hydrogen peroxide in exhaled air depends on expiratory flow rate. Eur Respir J 2000; 16 (6): 1115-1118
37. Beurden WJ van, Dekhuijzen PN, Harff GA et al. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002; 69 (3): 211-216
38. Lehmann C, Rothe M, Becher B. A new method for rapid measurement of hydrogen peroxide in exhaled breath condensate. Am J Respir Crit Care Med 2002; 165: 53 (Abstract)
39. Dohlman AW, Black HR, Royall JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993; 148 (4 Pt 1): 955-960
40. Antczak A, Nowak D, Shariati B et al. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Eur Respir J 1997; 10 (6): 1235-1241
41. Antczak A, Kurmanowska Z, Kasielski M et al. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Respir Med 2000; 94 (5): 416-421
42. Horvath I, Donnelly LE, Kiss A et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998; 158 (4): 1042-1046
43. Nowak D, Antczak A, Krol M et al. Increased content of hydrogen peroxide in the expired breath of cigarette smokers. Eur Respir J 1996; 9 (4): 652-657
44. Dekhuijzen PN, Aben KK, Dekker I et al. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154 (3 Pt 1): 813-816
45. Nowak D, Kasielski M, Pietras T et al. Cigarette smoking does not increase hydrogen peroxide levels in expired breath condensate of patients with stable COPD. Monaldi Arch Chest Dis 1998; 53 (3): 268-273
46. Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med 2001; 95 (6): 448-456
47. De Benedetto F, Aceto A, Dragani B et al. Validation of a new technique to assess exhaled hydrogen peroxide: results from normals and COPD patients. Monaldi Arch Chest Dis 2000; 55 (3): 185-188
48. Loukides S, Horvath I, Wodehouse T et al. Elevated levels of expired breath hydrogen peroxide in bronchiectasis. Am J Respir Crit Care Med 1998; 158 (3): 991-994
49. Loukides S, Bouros D, Papatheodorou G et al. Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest 2002; 121 (1): 81-87
50. Worlitzsch D, Herberth G, Ulrich M et al. Catalase, myeloperoxidase and hydrogen peroxide in cystic fibrosis. Eur Respir J 1998; 11 (2): 377-383
51. Jobsis Q, Raatgeep HC, Schellekens SL et al. Hydrogen peroxide and nitric oxide in exhaled air of children with cystic fibrosis during antibiotic treatment. Eur Respir J 2000; 16 (1): 95-100
52. Baldwin SR, Simon RH, Grum CM et al. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet 1986; 1 (8471): 11-14
53. Heard SO, Longtine K, Toth I et al. The influence of liposome- encapsulated prostaglandin E1 on hydrogen peroxide concentrations in the exhaled breath of patients with the acute respiratory distress syndrome. Anesth Analg 1999; 89 (2): 353-357
54. Nowak D, Kasielski M, Antczak A et al. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999; 93 (6): 389-396
55. Ferreira IM, Hazari MS, Gutierrez C et al. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. Am J Respir Crit Care Med 2001; 164 (6): 1012-1015
56. Beurden WJ van, Harff GA, Dekhuijzen PN et al. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002; 96 (3): 197-203
57. Zappacosta B, Persichilli S, Mormile F et al. A fast chemiluminescent method for H(2)O(2) measurement in exhaled breath condensate. Clin Chim Acta 2001; 310 (2): 187-191
58. Ho LP, Innes JA, Greening AP. Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide. Thorax 1998; 53 (8): 680-684
59. Kostikas K, Papatheodorou G, Ganas K et al. pH in Expired Breath Condensate of Patients with Inflammatory Airway Diseases. Am J Respir Crit Care Med 2002; 165 (10): 1364-1370
60. Corradi M, Pesci A, Casana R et al. Nitrate in exhaled breath condensate of patients with different airway diseases. Nitric Oxide 2003; 8 (1): 26-30
61. Cunningham S, McColm JR, Ho LP et al. Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. Eur Respir J 2000; 15 (5): 955-957
62. Formanek W, Inci D, Lauener RP et al. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002; 19 (3): 487-491
63. Kharitonov SA, Donnelly LE, Montuschi P et al. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002; 57 (10): 889-896
64. Hunt J, Byrns RE, Ignarro LJ et al. Condensed expirate nitrite as a home marker for acute asthma [letter]. Lancet 1995; 346 (8984): 1235-1236
65. Ganas K, Loukides S, Papatheodorou G et al. Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001; 95 (8): 649-654
66. Hanazawa T, Kharitonov SA, Barnes PJ. Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000; 162 (4 Pt 1): 1273-1276
67. Balint B, Kharitonov SA, Hanazawa T et al. Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur Respir J 2001; 17 (6): 1201-1207
68. Rothe M, Becher G, Kragl U et al. Bestimmung von Tyrosin und Nitrotyrosin im Atemkondensat von CF-Patienten. Pneumologie 2003; 57: S52 (Abstract)
69. Corradi M, Montuschi P, Donnelly LE et al. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001; 163 (4): 854-858
70. Driver AG, Kukoly CA, Ali S et al. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 1993; 148 (1): 91-97
71. Mann JS, Holgate ST, Renwick AG et al. Airway effects of purine nucleosides and nudeotides and release with bronchial provocation in asthma. J Appl Physiol 1986; 61 (5): 1667-1676
72. Vizi E, Huszar E, Csoma Z et al. Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol 2002; 109 (3): 446-448
73. Antczak A, Montuschi P, Kharitonov S et al. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166 (3): 301-306
74. Montuschi P, Kharitonov SA, Ciabattoni G et al. Exhaled leukotrienes and prostaglandins in COPD. Thorax 2003; 58 (7): 585-588
75. Reinhold P, Becher G, Rothe M. Evaluation of the measurement of leukotriene B4 concentrations in exhaled condensate as a noninvasive method for assessing mediators of inflammation in the lungs of calves. Am J Vet Res 2000; 61 (7): 742-749
76. Csoma Z, Kharitonov SA, Balint B et al. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002; 166 (10): 1345-1349
77. Neubauer B, Struck N, Mutzbauer TS et al. Leukotriene-B4 concentrations in exhaled breath condensate and lung function after thirty minutes of breathing technically dried compressed air. Int Marit Health 2002; 53 (1-4): 93-101
78. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002; 109 (4): 615-620
79. Becher G, Winsel K, Beck E et al. Leukotriene B4 in breathing condensate of patients with bronchopulmonary diseases and of normal patients. Appl Cardiopulmon Pathophysiol 1995; 5: 215-219
80. Baraldi E, Carraio S, Alinovi R et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58 (6): 505-509
81. Cap P, Pehal F, Petru V et al. Leukotrienes in breath condensate in patients with asthma and COPD. Alergie 2002; 1: 15-20.
82. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001; 280 (6): L1067-1082
83. Baraldi E, Ghiro L, Piovan V et al. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003; 124 (1): 25-31
84. Montuschi P, Collins JV, Ciabattoni G et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000; 162 (3 Pt 1): 1175-1177
85. Montuschi P, Ciabattoni G, Paredi P et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998; 158 (5 Pt 1): 1524-1527
86. Montuschi P, Kharitonov SA, Ciabattoni G et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000; 55 (3): 205-209 [Record as supplied by publisher]
87. Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 1998; 114 (6): 1653-1659
88. Carpagnano GE, Kharitonov SA, Resta O et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 2002; 122 (4): 1162-1167
89. 2 and thiobarbituric acid reactive substances (TBARs) by healthy subjects. Free Radic Biol Med 2001; 30 (2): 178-186
90. Larstad M, Ljungkvist G, Olin AC et al. Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 766 (1): 107-114
91. Mates M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000; 153 (1-3): 83-104
92. Hunt JF, Fang K, Malik R et al. Endogenous airway acidification. Implications for asthma pathophysiology [see comments]. Am J Respir Crit Care Med 2000; 161 (3 Pt 1): 694-699
93. Tate S, MacGregor G, Davis M et al. Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 2002; 57 (11): 926-929
94. Vaughan J, Ngamtrakulpanit L, Pajewski T et al. Exhaled breath condensate pH is a robust and reproducible assay of airway chemistry. Eur Respir J 2003; in press
95. Hunt JF, Erwin E, Palmer L et al. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med 2002; 165 (1): 101-107
96. Ho LP, Faccenda J, Innes JA et al. Expired hydrogen peroxide in breath condensate of cystic fibrosis patients. Eur Respir J 1999; 13 (1): 103-106
97. McRae K, De Perrot M, Fischer S et al. Detection of 1L-10 in the exhaled breath condensate, plasma and tissue during ischemia-reperfusion injury in experimental lung transplantation. J Heart Lung Transplant 2001; 20 (2): 184
98. Carpagnano GE, Kharitonov SA, Wells AU et al. Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease. Respiration 2003; 70 (2): 154-160
99. Nayeri F, Millinger E, Nilsson I et al. Exhaled breath condensate and serum levels of hepatocyte growth factor in pneumonia. Respir Med 2002; 96 (2): 115-119